Hi Guest
X
Real-Time Quote
Enter Company or MFGlaxoSmithKline Pharmaceuticals Ltd. - Research Center
Results | |
Statement |
Balance sheet
|
More |
(Rs crore)
Balance sheet
| Dec ' 08 | Dec ' 07 | Dec ' 06 | Dec ' 05 | Dec ' 04 | |
|---|---|---|---|---|---|
Sources of funds | |||||
| Owner's fund | |||||
| Equity share capital | 84.70 | 84.70 | 84.70 | 84.70 | 87.32 |
| Share application money | - | - | - | - | - |
| Preference share capital | - | - | - | - | - |
| Reserves & surplus | 1,456.39 | 1,276.21 | 1,110.01 | 863.90 | 836.94 |
Loan funds | |||||
| Secured loans | - | - | - | - | - |
| Unsecured loans | 5.65 | 5.77 | 5.54 | 4.85 | 3.84 |
| Total | 1,546.74 | 1,366.68 | 1,200.25 | 953.46 | 928.11 |
Uses of funds | |||||
| Fixed assets | |||||
| Gross block | 282.15 | 266.71 | 253.63 | 253.11 | 252.64 |
| Less : revaluation reserve | - | - | - | - | - |
| Less : accumulated depreciation | 191.75 | 179.24 | 167.83 | 171.54 | 165.66 |
| Net block | 90.40 | 87.47 | 85.80 | 81.57 | 86.98 |
| Capital work-in-progress | 9.95 | 5.43 | 8.66 | 15.37 | 4.51 |
| Investments | 751.87 | 1,333.32 | 1,139.41 | 913.06 | 776.83 |
Net current assets | |||||
| Current assets, loans & advances | 1,429.73 | 587.60 | 542.83 | 502.98 | 544.60 |
| Less : current liabilities & provisions | 735.21 | 647.14 | 576.44 | 559.52 | 484.80 |
| Total net current assets | 694.52 | -59.54 | -33.62 | -56.54 | 59.80 |
| Miscellaneous expenses not written | - | - | - | - | - |
| Total | 1,546.74 | 1,366.68 | 1,200.25 | 953.46 | 928.11 |
Notes: | |||||
| Book value of unquoted investments | 444.67 | 1,081.70 | 907.67 | 486.59 | 327.25 |
| Market value of quoted investments | 306.84 | 504.07 | 364.91 | 525.81 | 510.13 |
| Contingent liabilities | 190.96 | 208.40 | 264.97 | 142.49 | 127.97 |
| Number of equity sharesoutstanding (Lacs) | 847.03 | 847.03 | 847.03 | 847.03 | 873.23 |